Robotic Surgery for Prostate Cancer

N/A

Waitlist Available

Led By Steven Clinton, MD

Research Sponsored by Ohio State University Comprehensive Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

ARM B: Patients with prostate cancer that will undergo robotic radical prostatectomy at The Arthur G. James Cancer Hospital and Solove Research Institute, The Ohio State University Medical Center. Ability to understand and willingness to sign the written informed consent document. 18 years and older

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 5 years

Awards & highlights

No Placebo-Only Group

Summary

This trial looks at the surgical outcomes of men who had robot-assisted surgery to remove their prostate.

Who is the study for?

This trial is for men aged 18 or older with prostate cancer who are either scheduled to undergo or have already undergone robotic radical prostatectomy at The Arthur G. James Cancer Hospital and Solove Research Institute, Ohio State University Medical Center.

What is being tested?

The study is analyzing the surgical outcomes of patients who have had their prostates removed using a robot-assisted technique known as robotic radical prostatectomy.

What are the potential side effects?

While this study focuses on outcomes rather than side effects, typical risks of robotic prostate surgery may include urinary incontinence, erectile dysfunction, and general surgical risks like infection.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am over 18, have prostate cancer, and will have surgery at The Arthur G. James Cancer Hospital.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Arm BExperimental Treatment1 Intervention

Patients with prostate cancer that will undergo robotic radical prostatectomy at The Arthur G. James Cancer Hospital and Solove Research Institute, The Ohio State University Medical Center .

Group II: Arm AActive Control1 Intervention

Patients with prostate cancer who have undergone robotic radical prostatectomy at The Arthur G. James Cancer Hospital and Solove Research Institute, The Ohio State University Medical Center.

0 / 1Eligibility criteria met